I-Minerals Files 43-101 Report Covering Preliminary Economic Assessment Study of its Bovill Kaolin Halloysite Quartz and K-Spar Project in Latah County, Idaho USA. PR Newswire VANCOUVER, British...
i-minerals Announces Positive Results of the Preliminary Economic Assessment Study of Its Bovill Kaolin Halloysite Quartz and K-Spar Project in Latah County, Idaho USA. -- US$155 million After...
i-minerals Completes Drilling of Bovill Kaolin Project PR Newswire VANCOUVER, British Columbia, Nov. 16, 2011 VANCOUVER, British Columbia, Nov. 16, 2011 /PRNewswire/ -- i-minerals inc. (TSX.V:...
i-minerals Begins Pilot Plant Production of High Purity Quartz Products PR Newswire VANCOUVER, British Columbia, Nov. 8, 2011 VANCOUVER, British Columbia, Nov. 8, 2011 /PRNewswire/ -- i-minerals...
i-minerals Begins Drilling of Bovill Kaolin Deposits to Upgrade Halloysite Resource PR Newswire VANCOUVER, British Columbia, Sept. 29, 2011 VANCOUVER, British Columbia, Sept. 29, 2011...
High Pure Quartz Product Produced From Basic Flotation of Primary Clay Material PR Newswire VANCOUVER, British Columbia, July 28, 2011 VANCOUVER, British Columbia, July 28, 2011 /PRNewswire/...
WALTHAM, Mass., Feb. 23 /PRNewswire-FirstCall/ -- Inverness Medical Innovations, Inc. (NYSE:IMA), a global leader in enabling individuals to take charge of their health at home through the...
Acquires Majority Ownership of Standard Diagnostics WALTHAM, Mass., Feb. 1 /PRNewswire-FirstCall/ -- Inverness Medical Innovations Inc. (NYSE:IMA) announced today that its tender offer for...
WALTHAM, Mass., Feb. 1 /PRNewswire-FirstCall/ -- Inverness Medical Innovations, Inc. (NYSE:IMA), a global leader in enabling individuals to take charge of their health at home through the merger...
WALTHAM, Mass., Jan. 11 /PRNewswire-FirstCall/ -- Inverness Medical Innovations, Inc. (NYSE:IMA), a global leader in enabling individuals to take charge of their health at home through the...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales